Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | GEN3009 |
Synonyms | |
Therapy Description |
GEN3009 is a bivalent CD37 monoclonal antibody with enhanced hexamerization ability, which potentially induces antibody-dependent cell-mediated cytotoxicity, antibody-dependent cellular phagocytosis, and complement-dependent cytotoxicity, and results in reduced tumor growth (PMID: 32341336). |